| abstract |
The present invention provides a stable and clear aqueous liquid preparation, characterized in that it contains (3-{2-[4-isopropyl-2-(4-trifluoromethyl)phenyl-5-thiazolyl]ethyl base}-5-methyl-1,2-benzisoxazol-6-yl) glycolic acid or its pharmaceutically acceptable salt as an active ingredient, and compounded by the formula: [C 6 H 5 CH 2 N Benzalkonium chloride represented by (CH 3 ) 2 R]Cl (wherein R is an alkyl group having 8 to 18 carbon atoms). |